Eiger BioPharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
18,370.00
84,948.00
4,778.00
59,936.00
41,779.00
100,353
Other Current Assets
180.00
3,135.00
717.00
581.00
712.00
1,492
Total Current Assets
18,550.00
88,083.00
5,495.00
60,517.00
42,491.00
101,845
Net Property, Plant & Equipment
308.00
763.00
41.00
76.00
79.00
167
Total Investments and Advances
-
-
-
65.00
-
-
Other Assets
2,296.00
264.00
46.00
78.00
312.00
436
Total Assets
21,154.00
89,110.00
5,582.00
60,736.00
42,882.00
102,448
ST Debt & Current Portion LT Debt
1,044.00
1.00
5,444.00
-
2,002.00
Accounts Payable
1,397.00
3,293.00
-
-
3,183.00
Other Current Liabilities
4,119.00
3,312.00
2,946.00
5,288.00
2,084.00
Total Current Liabilities
6,560.00
6,606.00
8,390.00
5,288.00
7,269.00
Long-Term Debt
-
10,102.00
-
14,727.00
13,091.00
Other Liabilities
37.00
298.00
2,344.00
-
-
Total Liabilities
6,597.00
17,006.00
10,734.00
20,015.00
20,360.00
Common Equity (Total)
50,991.00
72,104.00
27,719.00
40,721.00
22,522.00
Total Shareholders' Equity
14,557.00
72,104.00
5,152.00
40,721.00
22,522.00
Total Equity
14,557.00
72,104.00
5,152.00
40,721.00
22,522.00
Liabilities & Shareholders' Equity
21,154.00
89,110.00
5,582.00
60,736.00
42,882.00
Preferred Stock (Carrying Value)
65,548.00
-
22,567.00
-
-
About Eiger BioPharmaceuticals
View Profile
